ReviewFrontiers in synaptic neuroscience2022

Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer's and Parkinson's diseases.

Christian HölscherPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.